QPS Clinical NL Sept 2026

Greetings!

Welcome to the Monthly QPS Clinical Newsletter

Discover how the QPS Data Analysis teams can accelerate expanded drug labels and claims with Real-World Evidence studies, learn how QPS Pharmacovigilance teams can confidently support the safety of your studies, and catch up on the latest science news on the QPS Blog.

Going to CPHI October 6-7, 2026 in Milan?

Schedule a meeting with the QPS team.

Kumar Ramu, PhD

Sr. VP,

Managing Director,

India

Ravinder Tangallapelli

Asst. General Mgr, Business Development, India

Joelle Kasbo

Sr. Director,

Business Development

Meghan De Young

Sr. Director,

Business

Development

Schedule a Meeting with QPS at CPHI

Real-World Insights That Move Therapies Forward

At QPS, we leverage Real-World Evidence (RWE) to transform drug development, expand drug labels and label claims, and enhance patient outcomes.

RWE helps biotech innovators bridge critical gaps in clinical research, reduce dependence on animal models, design more diverse and representative studies, support enhanced drug labels and claims, and accelerate the path to life-changing therapies for patients.

Download the White Paper

Expanding Drug Labels with Real-World Evidence

Strengthen Patient Safety with Pharmacovigilance at QPS

Protect patients, reduce compliance risk, and keep your clinical program moving forward with QPS Pharmacovigilance.

Our global experts combine proactive safety monitoring, integrated medical oversight, and the industry-standard Argus Safety Database to deliver reliable, audit-ready support throughout every phase of development.

Partner with QPS to manage safety with confidence, from study planning through post-market surveillance.

SPEAK WITH A CLINICAL DEVELOPMENT EXPERT

Discover the Future of Science on the QPS Blog

Stopping Genetic Expansion Could Transform Huntington’s Disease and More

For years, drug development for Huntington’s disease has focused on reducing the toxic huntingtin protein produced by the mutant HTT gene. That strategy remains…

A New Development Strategy Takes Shape

Gene Therapy at QPS

Disarming the Gut Toxin Behind Colon Cancer

Colorectal cancer is a stealthy killer, causing as many as 900,000 deaths each year, per the most recent World Health Organization data. As the…

Leveraging the Findings for a Cancer-Prevention Drug

Oncology Clinical Trials at QPS

Subscribe to the QPS Blog

Contact the Experts at QPS

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Contact QPS Today

Visit our website www.qps.com

or contact us at infopr@qps.com

to start your next study.

View as Webpage

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)